About LaVision BioTec
LaVision BioTec is a Healthcare company based in Bielefeld (Germany) founded in 2000 by Heinrich Spiecker, and was acquired by Miltenyi Biotec in October 2018. Microscopes for cell analysis and preclinical imaging are developed. The company has 102 employees. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems. Its legal entity is LaVision BioTec GmbH.
Company details
LaVision BioTec was founded in 2000 and is based in Bielefeld, Germany, within the biotechnology sector. Advanced microscopy systems for cell analysis and preclinical imaging are produced by the company. Key offerings include light sheet microscopes for fluorescence imaging, horizontal photon laser scanning microscopes, modular 2-photon platforms, doubleheader microscopes, and endomicroscopes. These tools are utilized in fields such as neuroscience, immunology, oncology, and developmental biology.
- Headquarters Bielefeld, Germany
- Employees 102
- Founders Heinrich Spiecker
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lavisionbiotec.com
- Social LinkedIn X
- Acquired by Miltenyi Biotec (Oct 2018)
- Legal Name Lavision Biotec Gmbh
- Latest Funding Round$901.28K (USD), Grant
Jan 2022
- InvestorsMiltenyi Biotec
& 1 more
- Employee Count102
- Acquired byMiltenyi Biotec
(Oct 2018)
Funding Insights of LaVision BioTec
- Total Rounds 2
- Last Round Grant — $901,282
- First Round $383,447
(Jan 2021)
- Investors Count 1
All 2 funding rounds of LaVision BioTec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2022 | $901,282 | Grant | – | – | |
| Jan 2021 | $383,447 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in LaVision BioTec
LaVision BioTec has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Miltenyi Biotec and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Develops tools and products for research and clinical application | 1989 | miltenyibiotec.com | Bergisch Gladbach, Germany |
Investor details for LaVision BioTec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LaVision BioTec
1 people are tracked at LaVision BioTec (1 in leadership); the tracked headcount is 102.
| Name | Role | Group |
|---|---|---|
Heinrich Spiecker | Founder & MD | Leadership |
Complete people profiles for LaVision BioTec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of LaVision BioTec
4 dated milestones of LaVision BioTec across 22 years, from founding to its latest funding, stage changes and deals.
- Founded LaVision BioTec is founded.
- Exit Acquired by Miltenyi Biotec.
- Funding First funding round of $383K.
- Funding Latest funding round, Grant, of $901K.
Web traffic of LaVision BioTec
Websites that share an audience with LaVision BioTec (lavisionbiotec.com).
Websites whose visitors overlap most with LaVision BioTec. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| intelligent-imaging.com | 100% | 7.8K | #3,028,656 | View details | |
| bitplane.com | 100% | 2K | #8,139,080 | View details | |
oko-lab.com | oko-lab.com | 100% | #3,086,698 | – | |
cifweb.unil.ch | cifweb.unil.ch | 97% | – | ||
blog.f1000.com | blog.f1000.com | 94% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for LaVision BioTec
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LaVision BioTec
LaVision BioTec was founded in 2000 and raised its 1st funding round 21 years after it was founded.
LaVision BioTec is headquartered in Bielefeld, Germany. It is registered at Bielefeld, North Rhine-westphalia, Germany.
LaVision BioTec has 102 employees.
LaVision BioTec was founded in 2000 and is based in Bielefeld, Germany, within the biotechnology sector. Advanced microscopy systems for cell analysis and preclinical imaging are produced by the company. Key offerings include light sheet microscopes for fluorescence imaging, horizontal photon laser scanning microscopes, modular 2-photon platforms, doubleheader microscopes, and endomicroscopes. These tools are utilized in fields such as neuroscience, immunology, oncology, and developmental biology.
LaVision BioTec has 2 investors. Key investors include Miltenyi Biotec, and European Union.
LaVision BioTec operates through Lavision Biotec Gmbh.
Yes. LaVision BioTec was acquired by Miltenyi Biotec in October 2018.